CLC bio's new database is scalable and fully customisable, making it attractive to research organisations from small university departments and clinical labs to large biotech and pharmaceutical firms
CLC bio has announced a November 2007 release of its Bioinformatics Database.
This software - currently in beta-testing - enables users of CLC bio's DNA, RNA, and protein sequence analysis software to store and work on their sequence data in a central, shared, and secure relational database.
The software is aimed at organisations wishing to profit from the considerable business value of selecting a modern and flexible bioinformatics platform.
Jan Lomholdt, vice president of global sales at CLC bio, states: "With this powerful and highly customisable solution for data sharing and efficient workflow support, CLC bio is leaping forward.
"Many academic and industrial customers have asked for a solution to share, manage and secure their valuable bioinformatics data, and we are proud to announce that we - as always - have developed what our customers ask for.
"CLC Bioinformatics Database raises the bar for what users can expect from a database, as the development team has focused heavily on eliminating classic obstacles such as different operating systems, limited support for database formats, or limited access to a central storage facility".
As with other of CLC bio products, Bioinformatics Database is cross-platform, running on Mac OS X, Windows, and Linux.
This will enable users across various workgroups to work on data in a central, shared, and secure relational database.
For the benefit of the diverse base of more than 50,000 existing users, CLC Bioinformatics Database integrates and runs smoothly with several types of databases, including Oracle, PostgreSQL, and MySQL.
Furthermore it is the customer's choice whether it should run as a stand-alone database, or if it should be fully customised and integrated with the customer's existing database or even multiple databases.